Masoud Mohebbi

Dr. Masoud Mohebbi


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 September 2018 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
NGNayereh Ghomian
Nayereh Ghomian
SVSeyede Houra Mousavi Vahed
Seyede Houra Mousavi Vahed
SFSamaneh Firouz
Samaneh Firouz
MYMohammad Ali Yaghoubi
Mohammad Ali Yaghoubi
MMMasoud Mohebbi
Masoud Mohebbi
Amirhossein SahebkarAmirhossein Sahebkar
Amirhossein Sahebkar

22 July 2019 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Closed access
MBMehdi Bakhshaee
Mehdi Bakhshaee
MSMohammadreza Sharifian
Mohammadreza Sharifian
FEFreshteh Esmatinia
Freshteh Esmatinia
BRBashir Rasoulian
Bashir Rasoulian
MMMasoud Mohebbi
Masoud Mohebbi

25 July 2018 in Electronic Physiciane
Verified
Journal Article
Open access
FMFatemeh Mahjoub
Fatemeh Mahjoub
RSRoshanak Salari
Roshanak Salari
MYMahdi Yousefi
Mahdi Yousefi
MMMasoud Mohebbi
Masoud Mohebbi
ASAzadeh Saki
Azadeh Saki
KRKambiz Akhavan Rezayat
Kambiz Akhavan Rezayat
Effect of Pistacia atlantica kurdica gum on diabetic gastroparesis symptoms: a randomized, triple-blind placebo-controlled clinical trial

5 September 2021 in Clinical Case Reports
Verified
Journal Article
Open access
PDF file
NMNasrin Milani
Nasrin Milani
MNMaryam Najafpour
Maryam Najafpour
MMMasoud Mohebbi
Masoud Mohebbi
Thyroid storm is an uncommon life‐threatening thyroid dysfunction which was observed for the first time among patients infected with Coronavirus 2019 (COVID‐19). The diagnosis and treatment of the rare thyroid distinctions such as thyroid storm in COVID‐19–infected patients should be critically considered alongside common treatments of COVID‐19 infection.

5 August 2021 in Endocrinology, Diabetes & Metabolism
Verified
Journal Article
Open access
PDF file
SNSoudabeh Nikooei Noghani
Soudabeh Nikooei Noghani
NMNasrin Milani
Nasrin Milani
MAMozhgan Afkhamizadeh
Mozhgan Afkhamizadeh
MKMona Kabiri
Mona Kabiri
SBShokoufeh Bonakdaran
Shokoufeh Bonakdaran
MMMasoud Mohebbi
Masoud Mohebbi
Background: Primary hyperparathyroidism (PHPT) can lead to renal and skeletal disorders, as well as insulin resistance and impaired glucose metabolism. The current study aimed to assess the effects of parathyroidectomy on insulin resistance in patients with PHPT.Materials and Methods: The present study was conducted on 65 patients with PHPT and indications for parathyroidectomy who were referred to the endocrinology clinics of Mashhad University of Medical Sciences. Thereafter, the demographic characteristics of the patients were recorded. Blood tests, including haemoglobin A1c (HbA1c), fasting blood glucose (FBG) and insulin levels, were assessed one week before and three months after the surgery. The insulin resistance score (HOMA‐IR) was calculated and compared using the relevant formula.Results: A total of 65 participants with a mean age of 45.44 ± 9.59 years were included in the current study. In one‐month postoperative tests, mean scores of FBG (p < .05), insulin level (p < .05) and HbA1c (p < .05) were significantly reduced. Moreover, the HOMA‐IR index decreased in 51 patients after the surgery.Conclusion: According to our findings, parathyroidectomy can be effective in the reduction of insulin resistance and corresponding complications in patients with PHPT in the present short‐term study. However, it has yet to be confirmed as a treatment method for insulin resistance in these patients. Future long‐term studies are required to be done to investigate the effect of parathyroidectomy on insulin resistance.

18 September 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
ATAshkan Torshizian
Ashkan Torshizian
FHFatemeh Hashemi
Fatemeh Hashemi
NKNastaran Khoshhal
Nastaran Khoshhal
AGAlireza Ghodsi
Alireza Ghodsi
HRHoura Rastegar
Houra Rastegar
MMMasoud Mohebbi
Masoud Mohebbi
Aim: This study sought to compare two common risk stratification systems in terms of their diagnostic performance for the evaluation of thyroid malignancy. Methods: The American College of Radiology (ACR) Thyroid Imaging, Reporting and Data System (TI-RADS) and the American Thyroid Association (ATA) guidelines were compared among 571 thyroid nodules with definitive fine needle aspiration (FNA) cytology or postoperative histopathology. Ultrasound characteristics such as composition, echogenicity, shape, margin, size, and vascularity were assessed for each thyroid nodule. Diagnostic performance measures were determined and compared through receiver operating characteristic (ROC) curves, and decision curve analysis (DCA). Results: Of 571 nodules, 65 (11.4%) were malignant. The AUC, sensitivity, specificity, positive predictive value, and negative predictive value were 0.691, 49.2%, 84.9%, 29.6%, and 92.8% for ATA guideline, and 0.776, 72.3%, 79.2%, 30.9%, and 95.7%, for ACR TI-RADS, respectively. ACR TI-RADS was more sensitive (p = 0.003), while the ATA guideline was more specific (p < 0.001). DCA demonstrated that the ACR TI-RADS provided a greater net benefit than the ATA guideline. In addition, the net reduction in unnecessary biopsies is higher for ACR TI-RADS than ATA guidelines. The total number of indicated biopsies and unnecessary FNA rates were lower in ACR TI-RADS compared to ATA guideline (293 vs. 527 and 80.2 vs. 87.8). ACR TI-RADS presented no biopsy indication in seven malignant nodules (all categorized as TR2), whereas ATA guideline missed one. Hypoechogenicity was the most significant predictor of malignancy (OR = 8.34, 95% CI: 3.75–19.45), followed by a taller-than-wide shape (OR = 6.73, 95% CI: 3.07–14.77). Conclusions: Our findings suggest that each system has particular advantages in the evaluation of thyroid nodules. ACR TI-RADS reduces unnecessary FNA rates, however, malignant nodules categorized as TR2 might be missed using this system. Further evaluation of this group of nodules using Doppler and other ultrasound modalities is recommended.